(Q58496536)
Statements
A Phase II Study of Neoadjuvant Gemcitabine Plus Doxorubicin in Stage IIIB Breast Cancer: A Preliminary Report (English)
0 references
June 2001
0 references
28
0 references
57-61
0 references
No description defined
No description defined